Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
2.290
-0.040 (-1.72%)
Mar 20, 2026, 9:30 AM EDT - Market open
Processa Pharmaceuticals Market Cap
Processa Pharmaceuticals has a market cap or net worth of $6.09 million as of March 20, 2026. Its market cap has increased by 280.72% in one year.
Market Cap
6.09M
Enterprise Value
660.94K
1-Year Change
280.72%
Ranking
Category
Stock Price
$2.29
Market Cap Chart
Since October 2, 2020, Processa Pharmaceuticals's market cap has decreased from $34.40M to $6.09M, a decrease of -82.29%. That is a compound annual growth rate of -27.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 8.40M | 29.23% |
| Dec 31, 2025 | 6.50M | 124.14% |
| Dec 31, 2024 | 2.90M | -64.63% |
| Dec 29, 2023 | 8.20M | -53.41% |
| Dec 30, 2022 | 17.60M | -77.14% |
| Dec 31, 2021 | 77.00M | 10.47% |
| Dec 31, 2020 | 69.70M | 102.62% |
| Oct 2, 2020 | 34.40M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evogene | 7.77M |
| Pulmatrix | 7.74M |
| Kiora Pharmaceuticals | 7.54M |
| GridAI Technologies | 7.41M |
| SciSparc | 7.33M |
| Dogwood Therapeutics | 7.30M |
| Moolec Science | 7.20M |
| Xenetic Biosciences | 7.13M |